fluid, elevated total protein, elevated fluid pressure, and decreased glucose levels, suggesting bacterial meningitis. Simultaneously, Listeria was detected in blood and stool cultures. Ampicillin at 12 g/day was started, and the symptoms gradually improved over 79 days of antibiotics.
Both of these cases began with Listeria colitis that progressed to septicemia and meningitis. Listeria meningitis occurs during antibody therapy to fight tumor necrosis factor alpha and suppress cell-mediated immunity (2-4). In 2001, the U.S. Food and Drug Administration reported serious infections with Listeria and Legionella during tumor necrosis factor alpha blocker therapy. The number of patients with ulcerative colitis has increased in recent years, and tumor necrosis factor alpha blockers are often used with other immunosuppressants in both young and old patients. We must be alert for Listeria infections in patients taking immunosuppressants, especially tumor necrosis factor alpha blockers.
